Home > Insider Trading > Filing (0001104659-13-041506)

Filing Details

Accession Number:: 0001104659-13-041506
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-05-14 17:29:30
Reporting Period:: 2013-05-14

Filing Date:: 2013-05-14
Accepted Time:: 2013-05-14 17:29:30
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1463729	Receptos Inc.	RCPT	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1575843	Amir Nashat	10835 Road To The Cure, Suite 205 San Diego CA 92121		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-05-14	1,035,597	$7.73	1,035,597	No	4	C	Indirect	See Footnotes
Common Stock	Acquisiton	2013-05-14	151,343	$14.00	1,186,940	No	4	P	Indirect	See Footnotes

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	See Footnotes
No	4	P	Indirect	See Footnotes

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series B Preferred Stock	Disposition	2013-05-14	7,766,989	$0.00	1,035,597	$7.73

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Indirect

Footnotes

Beneficial ownership consists of; (i) 142,764 shares of common stock held by Polaris Venture Partners VI, L.P. ("Polaris Ventures"); (ii) 8,579 shares of common stock held by Polaris Venture Partners Founders' Fund VI, L.P. ("Polaris Fund"); (iii) an aggregate of 976,897 shares of common stock issued upon conversion of shares of Series B preferred stock held by Polaris Ventures; and (iv) an aggregate of 58,700 shares of common stock issued upon conversion of Series B preferred stock held by Polaris Fund. The general partner of Polaris Ventures and Polaris Fund is Polaris Venture Management Co. VI, LLC ("Polaris Management"), and Polaris Management has sole voting and investment power over such shares. Polaris Management disclaims beneficial ownership of all such shares, except to the extent of any pecuniary interest therein. Dr. Nashat is one of six members of Polaris Management.
He has shared voting and investment power over such shares and may be deemed the indirect beneficial owner of such shares. Dr. Nashat disclaims beneficial ownership over such shares, except to the extent of any pecuniary interest therein. The members of North Star Venture Management 2010 LLC are also members of Polaris Management, and as members of the general partner, they may be deemed to share voting and investment power over such shares. The principles of North Star Venture Management 2010 LLC disclaim beneficial ownership of such shares, except to the extent of their proportionate pecuniary interest therein.
The Series A Preferred Stock converted upon the closing of the Issuer's initial public offering at a conversion ratio of 1 share of Common Stock for every 7.5 shares of Series A Preferred Stock, for no additional consideration.